American Journal of Obstetrics & Gynecology
Volume 186, Issue 5 , Pages 962-968 , May 2002

Human papillomavirus detection for cervical cancer prevention with polymerase chain reaction in self-collected samples

Received 21 May 2001 ,Revised 5 September 2001 ,Accepted 19 December 2001.

References 

  1. Stockard CR, Papanicolaou GN. A rhythmical “heat period” in guinea pigs. Science. 1917;46:42–44
  2. Papanicolaou GN. New cancer diagnosis. Proceedings of the Third Race Betterment Conference. 1928;528–534
  3. Papanicolaou GN, Traut HF. Diagnosis of uterine cancer by the vaginal smear. New York: Commonwealth Fund; 1943;
  4. Morrison EAB, Gammon MD, Goldberg GL, Vermund SH, Burk RD. Pregnancy and cervical infection with human papillomaviruses. Int J Obstet Gynecol. 1996;54:125–130
  5. Fife KH, Katz BP, Roush J, Handy VD, Brown DR, Hansell R. Cancer-associated human papillomavirus types are selectively increased in the cervix of women in the first trimester of pregnancy. Am J Obstet Gynecol. 1996;174:1487–1493
  6. Kemp EA, Hakenwerth AM, Laurent SL, Gravitt PE, Stoerker J. Human papillomavirus prevalence in pregnancy. Obstet Gynecol. 1992;79:649–656
  7. Chang-Claude J, Schneider A, Smith E, Blettner M, Wahrensdorf J, Turek L. Longitudinal study of the effects of pregnancy and other factors on detection of HPV. Gynecol Oncol. 1996;60:355–362
  8. Tenti P, Zappatore R, Migliora P, Spinillo A, Maccarini U, Bendedittis M, et al.  Latent human papillomavirus infection in pregnant women at term: a case-control study. J Infect Dis. 1997;176:277–280
  9. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, et al.  Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphism, nucleotide sequence and phylogenetic algorithms. J Infect Dis. 1994;170:1077–1085
  10. Vermund SH, Schiffman MH, Goldberg GL, Ritter DB, Weltman A, Burk RD. Molecular diagnosis of genital human papillomavirus infection: comparison of two methods used to collect exfoliated cervical cells. Am J Obstet Gynecol. 1989;160:304–308
  11. Morrison EAB, Goldberg GL, Hagan RJ, Kadish AS, Burk RD. Self-administered home cervicovaginal: a novel tool for the clinical-epidemiologic investigation of genital human papillomavirus infections. Am J Obstet Gynecol. 1992;167:104–107
  12. Fairley CK, Chen S, Tabrizi SN, Quinn MA, McNeil JJ, Garland SM. Tampons: a novel patient-administered method for the assessment of genital human papillomavirus infection. J Infect Dis. 1992;165:1103–1106
  13. Moscicki A-B. Comparison between methods for human papillomavirus DNA testing: a model for self-testing in young women. J Infect Dis. 1993;167:723–725
  14. Harper DM, Hildesheim A, Cobb JL, Greenberg M, Vaught J, Lorincz AT. Collection devices for human papillomavirus. J Fam Pract. 1999;48:531–535
  15. Hillemanns P, Kimmig R, Huttermann U, Dannecker C, Thaler CJ. Screening for cervical neoplasia by self-assessment for human papillomavirus DNA [letter]. Lancet. 1999;354:1970
  16. Wright TC, Denny L, Kuhn L, Pollack A, Lorincz AT. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA. 2000;283:81–86
  17. Sellors JW, Lorincz AT, Mahony JB, Mielzynska I, Lytwyn A, Roth P, et al.  Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. CMAJ. 2000;163:513–518
  18. Lorenzato F, Singer A, Mould T, Santos LC, Maia A, Cariri L. Cervical cancer detection by hybrid capture and evaluation of local risk factors. Int J Gynecol Obstet. 2001;73:37–42
  19. Ratnam S, Franco EL, Ferenczy A. Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiol Biomarkers Prev. 2000;9:945–951
  20. Meijer CJLM, van den Brule AJC, Snijders PJF, Helmerhorst T, Kenemans P, Walboomers JMM. Detection of human papillomavirus in cervical scrapes by the polymerase chain reaction in relation to cytology: possible implications for cervical cancer screening. IARC Sci Publ. 1992;119:271–282
  21. Rozendaal L, Walboomers JMM, van der Linden JC, Voorhorst FJ, Kenemans P, Helmerhorst TJM, et al.  PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer. 1996;68:766–769
  22. Lorenzato F, Ho L, Terry G, Singer A, Santos LC, Batista RL, et al.  The use of human papillomavirus typing in detection of cervical neoplasia in Recife (Brazil). Int J Gynecol Cancer. 2000;10:143–150
  23. Peyton CL, Schiffman M, Lorincz AT, Hunt WC, Mielzynska I, Bratti C, et al.  Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol. 1998;36:3248–3254
  24. Siegfried E, Rasnick-Conley J, Cook S, Leonardi C, Monteleone J. Human papillomavirus screening in pediatric victims of sexual abuse. Pediatrics. 1998;1001:43–47
  25. Della Manna A, Montpetit S. A novel approach to obtaining reliable PCR results from luminol treated bloodstains. J Forensic Sci. 2000;45:886–890
  26. Hochmeister M, Rudin O, Meier R, Peccioli M, Borer U, Eisenberg A, et al.  A foldable cardboard box for drying and storage of by cotton swab collected biological samples. Arch Kriminol. 1997;3-4:113–120
  27. Zaal MJ, Volker-Dieben HJ, Wienesen M, D'Amaro J, Kijlstra A. Longitudinal analysis of varicella-zoster virus DNA on the ocular surface associated with herpes zoster ophthalmicus. Am J Ophthalmol. 2001;131:25–29
  28. van Der Schee C, van Belkum A, Zwijgers L, van Der Brugge E, O'Neill EL, Luijendijk A, et al.  Improved diagnosis of Trichomonas vaginalis infection by PCR using vaginal swabs and urine specimens compared to diagnosis by wet mount microscopy, culture, and fluorescent staining. J Clin Microbiol. 1999;37:4127–4130
  29. Buttner MP, Cruz-Perez P, Stetzenbach LD. Enhanced detection of surface-associated bacteria in indoor environments by quantitative PCR. Appl Environ Microbiol. 2001;67:2564–2570

☆ Supported by a grant (BEX 1178/96) from the Brazilian Government Teaching and Research Fund (CAPES).

☆☆ Reprint requests: Felipe Lorenzato, MD, Department of Molecular Pathology, University College London, 46 Cleveland St, London W1P 6DB, United Kingdom. E-mail: lorenzato@br.inter.net

PII: S0002-9378(02)06728-5

doi: 10.1067/mob.2002.122390

American Journal of Obstetrics & Gynecology
Volume 186, Issue 5 , Pages 962-968 , May 2002

Article Tools

* Image Usage & Resolution